Cargando…
Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting Cells
Adoptive cell therapy with ex vivo expanded tumor infiltrating lymphocytes or gene engineering T cells expressing chimeric antigen receptors (CAR) is a promising treatment for cancer patients. This production utilizes T-cell activation and transduction with activation beads and RetroNectin, respecti...
Autores principales: | Shrestha, Bishwas, Zhang, Yongliang, Yu, Bin, Li, Gongbo, Boucher, Justin C., Beatty, Nolan J., Tsai, Ho-Chien, Wang, Xuefeng, Mishra, Asmita, Sweet, Kendra, Lancet, Jeffrey E., Kelley, Linda, Davila, Marco L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077957/ https://www.ncbi.nlm.nih.gov/pubmed/31834208 http://dx.doi.org/10.1097/CJI.0000000000000306 |
Ejemplares similares
-
Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting Cells
por: Boucher, Justin C., et al.
Publicado: (2023) -
CD3 engagement as a new strategy for allogeneic “off-the-shelf” T cell therapy
por: Li, Gongbo, et al.
Publicado: (2022) -
Berberine displays antitumor activity in esophageal cancer cells in vitro
por: Jiang, Shu-Xian, et al.
Publicado: (2017) -
Intra-arterial Versus Intravenous Adoptive Cell Therapy in a Mouse Tumor Model
por: Visioni, Anthony, et al.
Publicado: (2018) -
Anti-TGF-β Antibody Combined with Dendritic Cells Produce Antitumor Effects in Osteosarcoma
por: Kawano, Masanori, et al.
Publicado: (2012)